Current through all regulations passed and filed through September 16, 2024
(A)
Informal peer
review.
(1)
All
medical staff members agree to cooperate in informal peer review activities
that are solely intended to improve the quality of medical care provided to
patients at the CHRI.
(2)
Information indicating a need for informal review,
including patient complaints, disagreements, questions of clinical competence,
inappropriate conduct and variations in clinical practice identified by the
clinical departments or divisions and medical staff committees shall be
referred to the chair of the practitioner evaluation committee.
(3)
The practitioner
evaluation committee chair or his or her designee may obtain information or
opinions from medical staff members or credentialed providers as well as
external peer review consultants pursuant to criteria outlined in these bylaws.
The information or opinions from the informal peer review may be presented to
the practitioner evaluation committee or another designated peer review
committee.
(4)
Following the assessment by the practitioner evaluation
committee chair or his or her designee, the practitioner evaluation committee
may make recommendations for educational actions of additional training,
sharing of comparative data or monitoring or provide other forms of guidance to
the medical staff member to assist him or her in improving the quality of
patient care. Such actions are not regarded as adverse, do not require
reporting to any governmental or other agency, and do not invoke a right to any
hearing.
(5)
At the conclusion of the evaluation, the practitioner
evaluation committee chair or his or her designee submits a report to the
applicable clinical department chief and the director of medical affairs. The
clinical department chief and the director of medical affairs shall evaluate
the matter to determine the appropriate course of action. They shall make an
initial written determination on whether:
(a)
The matter
warrants no further action;
(b)
Informal
resolution under this paragraph is appropriate. The clinical department chief
and the director of medical affairs shall determine whether to include
documentation of the informal resolution in the medical staff member's file. If
documentation is included in the member's file, the affected member shall have
an opportunity to review it and may make a written response which shall also be
placed in the file. Informal review under this paragraph is not a procedural
prerequisite to the initiation of formal peer review under paragraph (B) of
this rule; or
(c)
Formal peer review under paragraph (B) of this rule is
warranted. In cases where the clinical department chief and director of medical
affairs cannot agree, the matter shall be submitted and determined as set forth
in paragraph (B) of this rule.
(B)
Formal peer
review.
(1)
Formal peer review may be requested in more serious situations or where
informal review has not resolved an issue or whenever the activities or
professional conduct of a member of the medical staff of the CHRI:
(a)
Violates the
standards or aims of the medical staff or standards of professional
conduct;
(b)
Is considered to be disruptive to the operation of the
CHRI;
(c)
Violates the bylaws, rules and regulations of the
medical staff, the Wexner medical center board, or the board of trustees of the
Ohio state university;
(d)
Violates state or federal law; or
(e)
Is detrimental to
patient safety or to the delivery of patient care within the
CHRI.
(2)
Formal peer review may be initiated by the clinical
department chief, the department chairperson and/or division director, the
director of medical affairs, any member of the medical staff, the chief
executive officer of the CHRI, the dean of the college of medicine, any member
of the Wexner medical center board, or the vice president for health services.
All requests for formal peer review shall be in writing, shall be submitted to
the director of medical affairs, and shall be supported by reference to the
specific activities or conduct which constitute grounds for the requested
action.
(3)
The director of medical affairs shall promptly notify
the affected member of the medical staff, in a confidential manner, that a
request for formal peer review has been made, and inform the member of the
specific activities or conduct which constitute grounds for the requested
action. The director of medical affairs shall verify the facts related to the
request for formal peer review, and within thirty days, make a written
determination. If the director of medical affairs decides that no further
action is warranted, the director of medical affairs shall notify the person(s)
who filed the request for formal peer review and the member accused, in
writing, that no further action would be taken.
(4)
Whenever the
director of medical affairs determines that formal peer review is warranted and
that a reduction, suspension or revocation of clinical privileges could result,
the director of medical affairs shall refer the request for formal peer review
to the formal peer review committee. The affected member of the medical staff
shall be notified of the referral to the formal peer review committee, and be
informed that these medical staff bylaws shall govern all further proceedings.
The executive vice president for health sciences or designee shall exercise any
or all duties or responsibilities assigned to the director of medical affairs
under these rules for implementing corrective action and appellate procedure
only if:
(a)
The director of medical affairs is the medical staff member
charged;
(b)
The director of medical affairs is responsible for
having the charges brought against another medical staff member;
or
(c)
There is an obvious conflict of
interest.
(5)
The formal peer review committee shall investigate
every request and shall report in writing its findings and recommendations for
action to the appropriate clinical department chief and notice given to the
division director. In making its recommendation the formal peer review
committee may consider as appropriate, relevant literature and clinical
practice guidelines, all the opinions and views expressed throughout the review
process, and any information or explanations provided by the member under
review. Prior to making its report, the medical staff member against whom the
action has been requested shall be afforded an opportunity for an interview
with the formal peer review committee. At such interview, the medical staff
member shall be informed of the specific activities alleged to constitute
grounds for formal peer review, and shall be afforded the opportunity to
discuss, explain or refute the allegations against the medical staff member.
The medical staff member may furnish written or oral information to the formal
peer review committee at this time. However, such interview shall not
constitute a hearing, but shall be investigative in nature. The medical staff
member shall not be represented by an attorney at this interview. The written
findings and recommendations for action is expected to be submitted within
ninety days, unless an extension is deemed necessary by the
committee.
(6)
Upon receipt of the written report from the formal peer
review committee, the appropriate clinical department chief shall make his or
her own written determination and forward that determination along with the
findings and recommendations of the formal peer review committee to the
director of medical affairs, or if required by paragraph (B)(3) of this rule,
to the executive vice president for health sciences or
designee.
(7)
Following receipt of the recommendation from the
clinical department chief and the report from the formal peer review committee,
the director of medical affairs, or the executive vice president for health
sciences or designee, shall approve or modify the determination of the clinical
department chief. Following receipt of the report of the clinical department
chief, the director of medical affairs or executive vice president for health
sciences or designee shall decide whether the grounds for the requested
corrective action are such as should result in a reduction, suspension or
revocation of clinical privileges. If the director of medical affairs, or
executive vice president for health sciences or designee, decides the grounds
are not substantiated, the director of medical affairs will notify the formal
peer review committee; clinical department chief and if applicable, the
academic department chairperson; division director; person(s) who filed the
complaint and the affected medical staff member, in writing, that no further
action will be taken.
In the event the director of medical
affairs or executive vice president for health sciences or designee finds the
grounds for the requested corrective action are substantiated, the director of
medical affairs shall promptly notify the affected medical staff member of that
decision and of the affected medical staff member's right to request a hearing
before the medical staff administrative committee pursuant to rule
3335-111-06 of the
Administrative Code. The written notice shall also include a statement that the
medical staff member's failure to request a hearing in the timeframe prescribed
in rule 3335-111-06 of the
Administrative Code shall constitute a waiver of rights to a hearing and to an
appeal on the matter; a statement that the affected medical staff member shall
have the procedural rights found in rule
3335-111-06 of the
Administrative Code; and a copy of the rule
3335-111-06 of the
Administrative Code. This notification and an opportunity to exhaust the
administrative hearing and appeal process shall occur prior to the imposition
of the proposed corrective action unless the emergency provisions outlined in
paragraph (D) of this rule apply. This written notice by the director of
medical affairs shall be sent certified return receipt mail to the affected
medical staff member's last known address as determined by university
records.
(8)
If the affected member of the medical staff does not
make a written request for a hearing to the director of medical affairs within
thirty-one days after receipt of the adverse decision, it shall be deemed a
waiver of the right to any review by the medical staff administrative committee
to which the staff member might otherwise have been entitled on the
matter.
(9)
If a timely, written request for hearing is made, the
procedures set forth in rule
3335-111-06 of the
Administrative Code shall apply.
(C)
Composition of
the formal peer review committee.
(1)
When the determination that formal peer review is
warranted is made, the clinical department chief shall select three members of
the medical staff to serve on a formal peer review committee.
(2)
Whenever the
questions raised concern the clinical competence of the member under review,
the clinical department chief shall select members of the medical staff to
serve on the formal peer review committee who shall have similar levels of
training and qualifications as the member who is subject to formal peer
review.
(3)
An external review consultant may serve as a member of
the formal peer review whenever:
(a)
A determination is made by the clinical department
chief and the director of medical affairs that the clinical expertise needed to
conduct the review is not available on the medical staff;
(b)
The objectivity
of the review may be compromised due to economic considerations;
or
(c)
Whenever the director of medical affairs determines
that an external review is otherwise advisable.
If an external reviewer is recommended,
the clinical department chief shall make a written recommendation to the
director of medical affairs for selection of an external reviewer. The director
of medical affairs shall make the final selection of an external
reviewer.
(D)
Summary
suspension.
(1)
Notwithstanding the provisions of this rule, a member of
the medical staff shall have all or any portion of clinical privileges
immediately suspended or appointment terminated by the chief executive officer
or department chairperson and/or division director, whenever such action must
be taken when there is imminent danger to patients or to the patient care
operations. Such summary suspension shall become effective immediately upon
imposition and the chief executive officer will subsequently notify the medical
staff member in writing of the suspension. Such notice shall be by certified
return receipt mail to the affected medical staff member's last known address
as determined by university records.
(2)
A medical staff
member whose privileges have been summarily suspended or whose appointment has
been terminated shall be entitled to appeal the suspension pursuant to rule
3335-111-06 of the
Administrative Code. If the affected member of the medical staff does not make
a written request for a hearing to the chief executive officer within
thirty-one days after receipt of the adverse decision, it shall be deemed a
waiver of the affected member's right to any review by the medical staff
administrative committee of which the member might otherwise been entitled. If
a timely, written request for a hearing is made, the procedures set forth in
rule 3335-111-06 of the
Administrative Code shall apply.
(3)
Immediately upon
the imposition of a summary suspension, the chief executive officer in
consultation with the appropriate department chairperson and/or division
director, shall have the authority to provide for alternative medical coverage
for the patients of the suspended medical staff member who remain in the
hospital at the time of suspension. The wishes of the patient shall be
considered in the selection of such alternative medical coverage. While a
summary suspension is in effect, the member of the medical staff is ineligible
for reappointment to the medical staff. Medical staff and hospital
administrative duties and prerogatives are suspended during the summary
suspension.
(E)
Automatic suspension and termination.
(1)
Notwithstanding
the provisions of this rule, a temporary lapse of a medical staff member's
admitting privileges, effective until medical records are completed, may be
imposed automatically by the chief executive officer after a warning, in
writing, of delinquency for failure to complete medical records as defined by
the rules and regulations of the medical staff.
(2)
Action by the
state boards of licensure revoking or suspending a medical staff member's
licensure or placing the member on probation shall automatically impose the
same restrictions to that member's CHRI medical staff
privileges.
(3)
Failure to maintain the minimum required type and
amount of professional liability insurance with an approved insurer, shall
result in immediate and automatic suspension of a medical staff member's
appointment and privileges until such time as proof of appropriate insurance
coverage is furnished. In the event such proof is not provided within ten days
of notice of such suspension, the medical staff member or credentialed provider
shall be deemed to no longer comply with medical staff requirements under rule
3335-111-04 of the
Administration Code and automatically relinquish his or her appointment and
privileges.
(4)
Upon exclusion, debarment, or other prohibition from
participation in any state or federal health care reimbursement program, or a
federal procurement or non-procurement program, the medical staff member's
appointment and privileges shall immediately and automatically terminate,
unless resignation in lieu of automatic termination is permitted pursuant to
paragraph (A)(4) of rule
3335-43-04 of the Administrative
Code.
(5)
If a medical staff member pleads guilty to or is found
guilty of a felony which involves violence or abuse upon a person, conversion,
embezzlement, or misappropriation of property; fraud, bribery, evidence
tampering, or perjury; or a drug offense, the medical staff member's
appointment and privileges shall be immediately and automatically
terminated.
(6)
Whenever a medical staff member's drug enforcement
administration (DEA) or other controlled substances number is revoked, he or
she shall be immediately and automatically divested of his or her right to
prescribe medications covered by the number.
(7)
When a medical
staff member's DEA or other controlled substances number is suspended or
restricted in any manner, his or her right to prescribe medications covered by
the number is similarly automatically suspended or restricted during the term
of the suspension or restriction.
(8)
No medical staff
member shall be entitled to the procedural rights set forth in rule
3335-111-06 of the
Administrative Code as a result of an automatic suspension or termination. As
soon as practicable after the imposition of an automatic suspension, the
medical staff administrative committee shall convene to determine if further
corrective action is necessary. Any further action with respect to an automatic
suspension must be taken in accordance with this rule.
Replaces: 3335-111-05